Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Hyperfine Inc (HYPR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/26/2025: HYPR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -13.13% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/26/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 56.32M USD | Price to earnings Ratio - | 1Y Target Price 1.3 |
Price to earnings Ratio - | 1Y Target Price 1.3 | ||
Volume (30-day avg) 1936817 | Beta 0.94 | 52 Weeks Range 0.68 - 1.90 | Updated Date 04/1/2025 |
52 Weeks Range 0.68 - 1.90 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.55 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-18 | When - | Estimate -0.135 | Actual -0.14 |
Profitability
Profit Margin - | Operating Margin (TTM) -463.81% |
Management Effectiveness
Return on Assets (TTM) -35.29% | Return on Equity (TTM) -61.03% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 18095021 | Price to Sales(TTM) 4.37 |
Enterprise Value 18095021 | Price to Sales(TTM) 4.37 | ||
Enterprise Value to Revenue 1.4 | Enterprise Value to EBITDA -0.72 | Shares Outstanding 62776900 | Shares Floating 58785896 |
Shares Outstanding 62776900 | Shares Floating 58785896 | ||
Percent Insiders 8.7 | Percent Institutions 22 |
Analyst Ratings
Rating 3.67 | Target Price 1.23 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Hyperfine Inc
Company Overview
History and Background
Hyperfine, Inc. was founded in 2014 with the mission to reinvent MRI by developing portable, low-cost, and accessible imaging solutions. It went public through a SPAC merger in December 2021. The company's early focus was on developing the Swoopu00ae Portable MRI system.
Core Business Areas
- Portable MRI Systems: Hyperfine designs, manufactures, and sells portable MRI systems, primarily the Swoopu00ae system, for point-of-care imaging.
- Service and Support: Provides service, maintenance, and support for its installed base of MRI systems.
- Contrast Imaging: Hyperfine recently announced that it is working with researchers at Brown to create Contrast Imaging on its platform.
Leadership and Structure
Dr. Jonathan Rothberg is the founder and Chairman. Khan Siddiqui, MD, serves as the Chief Medical Officer and Chief Strategy Officer. The company has a standard corporate structure with functional departments such as R&D, Sales, Marketing, and Operations.
Top Products and Market Share
Key Offerings
- Swoopu00ae Portable MRI: Hyperfine's primary product is the Swoopu00ae Portable MRI system. This system is designed to be easily transportable and can be used at the point of care, such as in intensive care units or emergency departments. Market share data is currently limited as it is a niche product with limited adoption and faces competition from established MRI manufacturers. Competitors include Siemens Healthineers (SIEGY), GE Healthcare (GE), and Philips (PHG) in the broader MRI market.
Market Dynamics
Industry Overview
The medical imaging industry is large and competitive, with established players dominating the market for traditional MRI systems. There is a growing trend towards point-of-care diagnostics and portable imaging solutions.
Positioning
Hyperfine is positioned as an innovator in the portable MRI space, targeting a niche market segment with its Swoopu00ae system. Its competitive advantage lies in the portability and lower cost compared to traditional MRI systems.
Total Addressable Market (TAM)
The total addressable market for MRI is estimated at tens of billions of dollars globally. Hyperfine targets a smaller portion of this market focused on point-of-care imaging and smaller hospitals, estimated at around $1B. Hyperfine is aiming to expand the accessibility of MRI technology, potentially increasing the overall market size.
Upturn SWOT Analysis
Strengths
- Innovative portable MRI technology
- FDA clearance for point-of-care use
- Potential to expand access to MRI imaging
- Strong patent portfolio
Weaknesses
- Limited market adoption and commercial traction
- High cash burn rate
- Dependence on a single product
- Relatively new company with limited operational history
Opportunities
- Expanding into new clinical applications
- Partnerships with hospitals and healthcare systems
- International market expansion
- Further technological advancements in portable MRI
Threats
- Competition from established MRI manufacturers
- Regulatory hurdles and reimbursement challenges
- Technological obsolescence
- Economic downturn affecting hospital capital spending
Competitors and Market Share
Key Competitors
- SIEGY
- GE
- PHG
Competitive Landscape
Hyperfine faces stiff competition from well-established MRI manufacturers with significant resources and market share. Its advantage lies in its portable and lower-cost system, but it needs to overcome the perception of lower image quality and limited clinical applications compared to traditional MRI.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited given the company's relatively recent commercial launch. Early growth has been slow, but if more customers adopt the product, growth will accelerate.
Future Projections: Future growth projections depend on successful market penetration, product adoption, and expansion into new applications. Analyst estimates will be found on financial websites.
Recent Initiatives: Recent initiatives include expanding the sales and marketing team, developing new clinical applications for the Swoopu00ae system, and establishing partnerships with key healthcare providers.
Summary
Hyperfine is an early-stage company with an innovative portable MRI technology. Its success hinges on driving market adoption and overcoming challenges related to competition, reimbursement, and technological advancements. The company's strengths lie in its portability and accessibility, but it faces weaknesses in commercial traction and financial performance. The company's TAM and the need for portable MRI technology suggests that the company has solid growth opportunities.
Similar Companies
- GE
- PHG
- SIEMENS
Sources and Disclaimers
Data Sources:
- Hyperfine Inc. SEC Filings
- Company Website
- Analyst Reports (where available)
- Industry Research Reports
Disclaimers:
This analysis is based on available information and estimates. Financial data is subject to change. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hyperfine Inc
Exchange NASDAQ | Headquaters Guilford, CT, United States | ||
IPO Launch date 2021-01-27 | CEO, President & Director Ms. Maria Sainz | ||
Sector Healthcare | Industry Medical Devices | Full time employees 111 | Website https://hyperfine.io |
Full time employees 111 | Website https://hyperfine.io | ||
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States, Europe, and Middle Eastern Markets. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.